BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21646735)

  • 1. Heart type fatty acid binding protein is more sensitive than troponin I and creatine kinase myocardial band at early stage in determining myocardial injury caused by percutaneous coronary intervention.
    Ozdemir L; Elonu OH; Gocmen AY
    Int Heart J; 2011; 52(3):143-5. PubMed ID: 21646735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of human heart-type fatty acid-binding protein as an early diagnostic biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase-myocardial band.
    Ruzgar O; Bilge AK; Bugra Z; Umman S; Yilmaz E; Ozben B; Umman B; Meric M
    Heart Vessels; 2006 Sep; 21(5):309-14. PubMed ID: 17151819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of heart-type fatty acid binding protein in early detection of acute myocardial infarction in comparison with cTnI, CK-MB and myoglobin.
    Chen L; Guo X; Yang F
    J Huazhong Univ Sci Technolog Med Sci; 2004; 24(5):449-51, 459. PubMed ID: 15641689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart-type fatty acid-binding protein and myocardial creatine kinase enable rapid risk stratification in normotensive patients with pulmonary embolism.
    Langer M; Forkmann M; Richter U; Tausche AK; Sveric K; Christoph M; Ibrahim K; Günther M; Kolschmann S; Boscheri A; Barthel P; Strasser RH; Wunderlich C
    J Crit Care; 2016 Oct; 35():174-9. PubMed ID: 27481755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention.
    Nageh T; Sherwood RA; Harris BM; Byrne JA; Thomas MR
    Int J Cardiol; 2003 Dec; 92(2-3):285-93. PubMed ID: 14659867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of minor myocardial injury after successful percutaneous transluminal coronary angioplasty with or without stenting.
    Saadeddin SM; Habbab MA; Sobki SH; Ferns GA
    Med Sci Monit; 2000; 6(4):708-12. PubMed ID: 11208396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical detection of minor myocardial injury after elective, uncomplicated, successful percutaneous coronary intervention in patients with stable angina: clinical outcome.
    Saadeddin SM; Habbab MA; Sobki SH; Ferns GA
    Ann Clin Biochem; 2002 Jul; 39(Pt 4):392-7. PubMed ID: 12117443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart-type fatty acid binding protein as an adjunct to cardiac troponin-I for the diagnosis of myocardial infarction.
    Kim KS; Lee HJ; Kim K; Jo YH; Kim TY; Lee JH; Rhee JE; Suh GJ; Kim MR; Lee CC; Singer AJ
    J Korean Med Sci; 2011 Jan; 26(1):47-52. PubMed ID: 21218029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised Assessment of Treatment using Panel Assay of Cardiac markers--Contemporary Biomarker Evaluation (RATPAC CBE).
    Collinson PO; Gaze DC; Thokala P; Goodacre S
    Health Technol Assess; 2013; 17(15):v-vi, 1-122. PubMed ID: 23597479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the heart-type fatty acid binding protein in the early diagnosis of acute coronary syndrome and its comparison with troponin I and creatine kinase-MB isoform.
    Orak M; Ustündağ M; Güloğlu C; Ozhasenekler A; Alyan O; Kale E
    Am J Emerg Med; 2010 Oct; 28(8):891-6. PubMed ID: 20825920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of postoperative myocardial injury by heart-type fatty acid-binding protein in off-pump coronary artery bypass grafting surgery.
    Carmona P; Mateo E; Montoro A; Alós L; Coret M; Errando CL; Llagunes J; De Andrés J
    Rev Esp Anestesiol Reanim; 2015 Jan; 62(1):3-9. PubMed ID: 24746360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of heart-type fatty acid-binding protein for the early diagnosis of acute myocardial infarction.
    McMahon CG; Lamont JV; Curtin E; McConnell RI; Crockard M; Kurth MJ; Crean P; Fitzgerald SP
    Am J Emerg Med; 2012 Feb; 30(2):267-74. PubMed ID: 21208763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Predictive value of human fatty acid binding protein for myocardial ischemia and injury in perioperative period of cardiac surgery].
    Liu YH; Zhou YW; Tu ZG; Ji SY; Chen M; Huang ZY; Yang JA; Renneberg R; Wang Y; Nie ZY; Zhong A
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jun; 38(6):514-7. PubMed ID: 21033132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB.
    Okamoto F; Sohmiya K; Ohkaru Y; Kawamura K; Asayama K; Kimura H; Nishimura S; Ishii H; Sunahara N; Tanaka T
    Clin Chem Lab Med; 2000 Mar; 38(3):231-8. PubMed ID: 10905760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention-induced myocardial injury.
    Kazmi DH; Kapoor A; Sinha A; Ambesh P; Kashyap S; Khanna R; Kumar S; Garg N; Tewari S; Goel PK
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S365-S371. PubMed ID: 30595291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart-type, fatty-acid binding protein can be a diagnostic marker in acute coronary syndromes.
    Cavus U; Coskun F; Yavuz B; Ciftci O; Sahiner L; Aksoy H; Deniz A; Ozakin E; Aytemir K; Tokgozoglu L; Kabakci G
    J Natl Med Assoc; 2006 Jul; 98(7):1067-70. PubMed ID: 16895274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart-type fatty acid-binding protein (H-FABP) and highly sensitive troponin T (hsTnT) as markers of myocardial injury and cardiovascular events in elective percutaneous coronary intervention (PCI).
    Connolly M; Shand J; Kinnin M; Menown I; Kurth MJ; Lamont J; Mc Eneaney D
    QJM; 2018 Jan; 111(1):33-38. PubMed ID: 29040663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between creatine kinase MB, heart-type fatty acid-binding protein, and cardiac troponin T for detecting myocardial ischemic injury after cardiac surgery.
    Jo MS; Lee J; Kim SY; Kwon HJ; Lee HK; Park DJ; Kim Y
    Clin Chim Acta; 2019 Jan; 488():174-178. PubMed ID: 30389460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of persistent platelet reactivity despite aspirin therapy on cardiac troponin I and creatine kinase-MB levels after elective percutaneous coronary interventions.
    Gulmez O; Yildirir A; Kaynar G; Konas D; Aydinalp A; Ertan C; Ozin B; Muderrisoglu H
    J Thromb Thrombolysis; 2008 Jun; 25(3):239-46. PubMed ID: 17574519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.